Role of Dopamine D2 Receptor in Renal Inflammation and Injury
Role of Dopamine D2 Receptor in Renal Inflammation and Injury
批准号:
8335394
负责人:
Ines Armando
金额:
$33.39万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2016-06-30
关键词:
AccountingAcuteAffectAffinityBiological AssayBloodBlood PressureCardiovascular DiseasesCardiovascular systemCell ProliferationCell Surface ReceptorsCellsChronic Kidney FailureDevelopmentDiabetes MellitusDiseaseDisease ProgressionDistalDopamineDopamine D2 ReceptorDown-RegulationEarly treatmentEnd stage renal failureEndothelial CellsEssential HypertensionFamilyG-Protein-Coupled ReceptorsGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic screening methodHumanHypertensionImmuneIndividualInfiltrationInflammationInflammatoryInflammatory ResponseInfusion proceduresInjuryIon TransportKidneyKidney DiseasesLymphocyteMaintenanceMediator of activation proteinModelingMusNorepinephrineOrganOrgan failureOxidative StressPathogenesisPathway interactionsPatientsPlayPopulationPredispositionPrevalenceProductionProximal Kidney TubulesReactionReceptor GeneResearchRhodopsinRiskRoleScreening procedureTestingTherapeuticTubular formationWild Type Mouseautocrinechemokinecytokinedesignhigh riskin vivoinnovationmacrophagemonocytenerve supplyneutrophilnovelparacrinepreventprotective effectreceptorreceptor expressionreceptor functiontranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The prevalence of chronic kidney disease is rising sharply worldwide and affects 13.1% of the population in the USA. Hypertension is one of the major causes of renal injury. Low-grade inflammation is associated with cardiovascular disease and specifically with hypertension. Inflammation and oxidative stress are major mediators in the development and progression of renal disease. There is increasing evidence that genetic factors contribute to the susceptibility to renal disease associated with hypertension and it has been suggested that hypertension may cause progressive kidney disease only in genetically susceptible individuals. The genetic predisposition to chronic kidney disease is polygenic but so far only a few genes have been shown to be contributory. This project will test the overall novel hypothesis that the dopamine D2 receptor regulates the inflammatory reaction in the kidney and that impaired function of the D2 receptor results in renal inflammation and end-organ damage. Polymorphisms of the D2 receptor gene are commonly observed in humans and some of them have been associated with elevated blood pressure and even hypertension. Several polymorphisms of the D2 receptor result in decreased expression/function of the receptor. If our hypothesis proves to be correct, then individuals carrying these polymorphisms could be more vulnerable to renal injury when challenged with an insult such as elevated blood pressure. These results could then be critical for designing innovative genetic testing assays and therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Dopamine D2 Receptor in Renal Inflammation and Injury
-
批准号:8463359
-
项目类别:
-
资助金额:$15.87万
-
财政年份:2011
-
负责人:Ines Armando
-
依托单位:
Role of Dopamine D2 Receptor in Renal Inflammation and Injury
-
批准号:8716734
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2011
-
负责人:Ines Armando
-
依托单位:
Role of Dopamine D2 Receptor in Renal Inflammation and Injury
-
批准号:8236580
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2011
-
负责人:Ines Armando
-
依托单位:
Role of Dopamine D2 Receptor in Renal Inflammation and Injury
-
批准号:9229367
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2011
-
负责人:Ines Armando
-
依托单位:
Role of Dopamine D2 Receptor in Renal Inflammation and Injury
-
批准号:8521272
-
项目类别:
-
资助金额:$32.22万
-
财政年份:2011
-
负责人:Ines Armando
-
依托单位:
GRK4 & Development of Salt Sensitivity
-
批准号:8835132
-
项目类别:
-
资助金额:$26.13万
-
财政年份:2008
-
负责人:Ines Armando
-
依托单位:
GRK4 & Development of Salt Sensitivity
-
批准号:9034651
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2008
-
负责人:Ines Armando
-
依托单位:
GRK4 and development of salt sensitivity (R01HL092196)
-
批准号:8659817
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Ines Armando
-
依托单位:
海外基金